Therapy of hepatitis B -- viral suppression or eradication?
about
Pros and Cons of Peginterferon Versus Nucleos(t)ide Analogues for Treatment of Chronic Hepatitis B.Baseline value of intrahepatic HBV DNA over cccDNA predicts patient's response to interferon therapyImpact of liver steatosis on response to pegylated interferon therapy in patients with chronic hepatitis BModels for predicting hepatitis B e antigen seroconversion in response to interferon-α in chronic hepatitis B patientsResponse-guided therapy of regimens based on PEG-interferon for chronic hepatitis B using on-treatment hepatitis B surface antigen quantification: a meta-analysis.Safety and efficacy of two-step peginterferon α-2a treatment in patients of chronic hepatitis B with acute exacerbationTime for an active antiviral therapy for hepatitis B: An update on the management of hepatitis B virus infection.Role of viral factors in the natural course and therapy of chronic hepatitis B.Diagnosis of hepatitis B virus infection through serological and virological markers.Treatment of hepatitis B virus-infected patients: utility of therapeutic recommendations in developing countries.Entecavir for the long-term treatment of chronic hepatitis B.Cost-effectiveness analysis of entecavir versus lamivudine in the first-line treatment of Australian patients with chronic hepatitis B.Relationship between adhesion molecules and virological response to pegylated interferon-alpha-2a treatment in patients with chronic hepatitis B: A pilot study.The role of HBsAg levels in the current management of chronic HBV infection.Combination therapy of lamivudine and interferon-alpha in pediatric patients with chronic hepatitis B in Bangladesh: a safe and effective therapeutic approach for pediatric CHB patients in developing countries.Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patientsSequential therapy with adefovir dipivoxil and pegylated Interferon Alfa-2a for HBeAg-negative patients
P2860
Q33819124-34519A35-AB75-40A8-82FC-6AE6F8E2CEFAQ33918392-72080CE3-7266-4FF9-A265-189D093D343BQ35555702-5A398A14-0257-4773-B852-63C7D3F41AC7Q35594289-05979917-1762-41DE-AFCE-0CAFE6A4EC54Q35688409-D81E4E76-639A-4051-8C46-A00F0891B811Q36371537-A64477CE-686B-45A7-9234-83A5E9732E2FQ36642950-486606F9-7EAA-4D10-80DD-409476D12A1CQ37280144-94FFD0C1-018F-4C25-9B00-DA6AFE71E40BQ37345962-97C80F55-A8EF-474F-8D18-23FFF8E9CB9BQ37508051-2FDAB5E0-2CAD-42C1-8C07-66CC1E0449B3Q37626058-64656528-6348-48C8-B486-DB475BF4AEA1Q40140066-56936C31-1093-43FD-AC35-5EDE595667ABQ42244578-B414DFB1-F998-4266-95EB-096CE5B9FBE7Q42360905-A945154A-10D1-48B5-B44E-7F9B53BDFF0CQ42964132-384CC5B4-0C23-4CA0-AD41-596E3D6F9BE5Q57782730-8C9939A3-476C-4E9D-A913-5DA118F51C96Q58034401-9DBCF38F-8D5D-4225-8C9D-4CBD9706BD83
P2860
Therapy of hepatitis B -- viral suppression or eradication?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Therapy of hepatitis B -- viral suppression or eradication?
@ast
Therapy of hepatitis B -- viral suppression or eradication?
@en
type
label
Therapy of hepatitis B -- viral suppression or eradication?
@ast
Therapy of hepatitis B -- viral suppression or eradication?
@en
prefLabel
Therapy of hepatitis B -- viral suppression or eradication?
@ast
Therapy of hepatitis B -- viral suppression or eradication?
@en
P2860
P356
P1433
P1476
Therapy of hepatitis B -- viral suppression or eradication?
@en
P2093
Robert P Perrillo
P2860
P304
P356
10.1002/HEP.20970
P407
P433
P577
2006-02-01T00:00:00Z